By expenditures
| Name | Title | Type |
|---|---|---|
| Amy Schwabenlender | CEO | Auditee |
| Joseph Losada | CHIEF FINANCIAL OFFICER | Auditee |
| Carol Walker | DIRECTOR OF FINANCE | Auditee |
| Robert N Snyder | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 359538 | 2023 | 2025-06-23 | Snyder & Brown CPAS | $5.69M |
| 300528 | 2023 | 2024-03-29 | Snyder & Brown CPAS PLLC | $5.64M |
| 314376 | 2022 | 2023-03-21 | Snyder & Brown CPAS | $4.75M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 359538 | 2023 | 2025-06-23 | 1142275 | 2023-103 | Material Weakness | - | B |
| 359538 | 2023 | 2025-06-23 | 1142274 | 2023-102 | Material Weakness | - | B |
| 359538 | 2023 | 2025-06-23 | 1142273 | 2023-101 | Significant Deficiency | - | B |
| 359538 | 2023 | 2025-06-23 | 1142272 | 2023-103 | Material Weakness | - | B |
| 359538 | 2023 | 2025-06-23 | 1142271 | 2023-102 | Material Weakness | - | B |
| 359538 | 2023 | 2025-06-23 | 1142270 | 2023-101 | Significant Deficiency | - | B |
| 359538 | 2023 | 2025-06-23 | 1142269 | 2023-101 | Significant Deficiency | - | B |
| 359538 | 2023 | 2025-06-23 | 565833 | 2023-103 | Material Weakness | - | B |
| 359538 | 2023 | 2025-06-23 | 565832 | 2023-102 | Material Weakness | - | B |
| 359538 | 2023 | 2025-06-23 | 565831 | 2023-101 | Significant Deficiency | - | B |
| 359538 | 2023 | 2025-06-23 | 565830 | 2023-103 | Material Weakness | - | B |
| 359538 | 2023 | 2025-06-23 | 565829 | 2023-102 | Material Weakness | - | B |
| 359538 | 2023 | 2025-06-23 | 565828 | 2023-101 | Significant Deficiency | - | B |
| 359538 | 2023 | 2025-06-23 | 565827 | 2023-101 | Significant Deficiency | - | B |
| 300528 | 2023 | 2024-03-29 | 966078 | 2023-101 | Significant Deficiency | - | B |
| 300528 | 2023 | 2024-03-29 | 966077 | 2023-101 | Significant Deficiency | - | B |
| 300528 | 2023 | 2024-03-29 | 389636 | 2023-101 | Significant Deficiency | - | B |
| 300528 | 2023 | 2024-03-29 | 389635 | 2023-101 | Significant Deficiency | - | B |